# Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat

> **NCT03282045** · PHASE3 · COMPLETED · sponsor: **Bosnalijek D.D** · enrollment: 346 (actual)

## Conditions studied

- Sore Throat

## Interventions

- **DRUG:** Lysobact Complete Sprey
- **DRUG:** Tantum Verde® Spray
- **DRUG:** Pharyngal® Oromucosal Spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03282045
- **Lead sponsor:** Bosnalijek D.D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-05-24
- **Final completion:** 2018-05-24
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2021-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03282045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03282045, "Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03282045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*